147
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Change on the Repeatable Battery for the Assessment of Neuropsychological Status and its relationship to brain amyloid

ORCID Icon, , &
Pages 105-117 | Received 13 Jan 2023, Accepted 13 May 2023, Published online: 24 May 2023

References

  • Ahern, E., & Semkovska, M. (2017). Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis. Neuropsychology, 31(1), 52–72. https://doi.org/10.1037/neu0000319
  • Bondi, M. W., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Salmon, D. P., Libon, D. J., Au, R., Galasko, D., & Salmon, D. P. (2014). Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. Journal of Alzheimer’s Disease: JAD, 42(1), 275–289. https://doi.org/10.3233/JAD-140276
  • Bransby, L., Lim, Y. Y., Ames, D., Fowler, C., Roberston, J., Harrington, K., Snyder, P. J., Villemagne, V. L., Salvado, O., Masters, C. L., & Maruff, P. (2019). Sensitivity of a Preclinical Alzheimer’s Cognitive Composite (PACC) to amyloid beta load in preclinical Alzheimer’s disease. Journal of Clinical and Experimental Neuropsychology, 41(6), 591–600. https://doi.org/10.1080/13803395.2019.1593949
  • Burton, R. L., Enright, J., O’Connell, M. E., Lanting, S., & Morgan, D. (2015). RBANS embedded measures of suboptimal effort in dementia: Effort scale has a lower failure rate than the effort index. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 30(1), 1–6. https://doi.org/10.1093/arclin/acu070
  • Chang, H. I., Hsu, S. W., Kao, Z. K., Lee, C. C., Huang, S. H., Lin, C. H., Chang, H.-I., Liu, M.-N., & Chang, C. C. (2022). Impact of amyloid pathology in mild cognitive impairment subjects: The longitudinal cognition and surface morphometry data. International Journal of Molecular Sciences, 23(23), 14635. https://doi.org/10.3390/ijms232314635
  • Clark, J. H., Hobson, V. L., & O’Bryant, S. E. (2010). Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer’s disease and mild cognitive impairment. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 25(4), 318–326. https://doi.org/10.1093/arclin/acq023
  • Cooley, S. A., Heaps, J. M., Bolzenius, J. D., Salminen, L. E., Baker, L. M., Scott, S. E., & Paul, R. H. (2015). Longitudinal change in performance on the Montreal cognitive assessment in older adults. The Clinical Neuropsychologist, 29(6), 824–835. https://doi.org/10.1080/13854046.2015.1087596
  • Dansson, H. V., Stempfle, L., Egilsdottir, H., Schliep, A., Portelius, E., Blennow, K., Zetterberg, H., & Johansson, F. D., & Alzheimer’s Disease Neuroimaging, I. (2021). Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease. Alzheimer’s Research & Therapy, 13(1), 151. https://doi.org/10.1186/s13195-021-00886-5
  • De Jager, C. A., Hogervorst, E., Combrinck, M., & Budge, M. M. (2003). Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychological Medicine, 33(6), 1039–1050. https://doi.org/10.1017/s0033291703008031
  • Duff, K., Foster, N. L., Dennett, K., Hammers, D. B., Zollinger, L. V., Christian, P. E., Butterfield, R. I., Beardmore, B. E., Wang, A. Y., Morton, K. A., & Hoffman, J. M. 2013. Amyloid deposition and cognition in older adults: The effects of premorbid intellect. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 28(7), 665–671. https://doi.org/10.1093/arclin/act047.
  • Duff, K., Foster, N. L., & Hoffman, J. M. (2014). Practice effects and amyloid deposition: Preliminary data on a method for enriching samples in clinical trials. Alzheimer Disease and Associated Disorders, 28(3), 247–252. https://doi.org/10.1097/WAD.0000000000000021
  • Duff, K., Hobson, V. L., Beglinger, L. J., & O’Bryant, S. E. (2010). Diagnostic accuracy of the RBANS in mild cognitive impairment: Limitations on assessing milder impairments. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 25(5), 429–441. https://doi.org/10.1093/arclin/acq045
  • Duff, K., Humphreys Clark, J. D., O’Bryant, S. E., Mold, J. W., Schiffer, R. B., & Sutker, P. B. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: Sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 23(5), 603–612. https://doi.org/10.1016/j.acn.2008.06.004
  • Duff, K., Porter, S., Dixon, A., Suhrie, K., & Hammers, D. (2020). The independent living scale in amnestic mild cognitive impairment: Relationships to demographic variables and cognitive performance. Journal of Clinical and Experimental Neuropsychology, 42(7), 725–734. https://doi.org/10.1080/13803395.2020.1798884
  • Duff, K., & Ramezani, A. (2015). Regression-based normative formulae for the repeatable battery for the assessment of neuropsychological status for older adults. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 30(7), 600–604. https://doi.org/10.1093/arclin/acv052
  • Duff, K., Schoenberg, M. R., Patton, D. E., Mold, J., Scott, J. G., & Adams, R. A. (2004). Predicting change with the RBANS in a community dwelling elderly sample. Journal of the International Neuropsychological Society, 10, 828–834. https://doi.org/10.1017/S1355617704106048
  • Duff, K., Schoenberg, M. R., Patton, D., Paulsen, J. S., Bayless, J. D., Mold, J., SCOTT, J., & Adams, R. L. 2005. Regression-based formulas for predicting change in RBANS subtests with older adults. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 20(3), 281–290. https://doi.org/10.1016/j.acn.2004.07.007.
  • Duff, K., Suhrie, K. R., Hammers, D. B., Dixon, A. M., King, J. B., Koppelmans, V., & Hoffman, J. M. (2021). Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer’s disease. The Clinical Neuropsychologist, 1–17. https://doi.org/10.1080/13854046.2021.1995050
  • Edmonds, E. C., Delano-Wood, L., Clark, L. R., Jak, A. J., Nation, D. A., McDonald, C. R., Libon, D. J., Au, R., Galasko, D., Salmon, D. P., & Bondi, M. W., & Alzheimer’s Disease Neuroimaging, I. (2015). Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimer’s & Dementia: the Journal of the Alzheimer’s Association, 11(4), 415–424. https://doi.org/10.1016/j.jalz.2014.03.005
  • Enright, J., O’Connell, M. E., MacKinnon, S., & Morgan, D. G. (2015). Predictors of Completion of Executive-Functioning Tasks in a Memory Clinic Dementia Sample. Applied Neuropsychology. Adult, 22(6), 459–464. https://doi.org/10.1080/23279095.2014.992070
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6
  • Freilich, B. M., & Hyer, L. A. 2007. Relation of the repeatable battery for assessment of neuropsychological status to measures of daily functioning in dementia. Psychological Reports, 101(1), 119–129. https://doi.org/10.2466/pr0.101.1.119-129.
  • Gwizdala, K. L., Brouillete, R., Beyl, R., Johnson, W., Hebert, C., Carter, L., Harris, M., Newton, R. L., & Carmichael, O. T. (2022). Exercise effects on cognition in older African Americans: A pilot randomized trial. Frontiers in Aging Neuroscience, 14, 921978. https://doi.org/10.3389/fnagi.2022.921978
  • Hammers, D. B., Atkinson, T. J., Dalley, B. C., Suhrie, K. R., Beardmore, B. E., Burrell, L. D., Horn, K. P., Rasmussen, K. M., Foster, N. L., Duff, K., & Hoffman, J. M. (2017). Relationship between 18 F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults. The Clinical Neuropsychologist, 31(3), 531–543. https://doi.org/10.1080/13854046.2016.1278039
  • Hammers, D. B., Atkinson, T. J., Dalley, B. C., Suhrie, K. R., Horn, K. P., Rasmussen, K. M., … Hoffman, J. M. (2017). Amyloid positivity using [18F]flutemetamol-PET and cognitive deficits in nondemented community-dwelling older adults. American Journal of Alzheimer’s Disease and Other Dementias, 1533317517698795. https://doi.org/10.1177/1533317517698795
  • Hammers, D. B., Suhrie, K. R., Porter, S. M., Dixon, A. M., & Duff, K. (2020). Generalizability of reliable change equations for the RBANS over one year in community-dwelling older adults. Journal of Clinical and Experimental Neuropsychology, 42(4), 394–405. https://doi.org/10.1080/13803395.2020.1740654
  • Hammers, D. B., Suhrie, K. R., Porter, S. M., Dixon, A. M., & Duff, K. (2022). Validation of one-year reliable change in the RBANS for community-dwelling older adults with amnestic mild cognitive impairment. The Clinical Neuropsychologist, 36(6), 1304–1327. https://doi.org/10.1080/13854046.2020.1807058
  • Heyanka, D. J., Scott, J. G., & Adams, R. L. (2015). Improving the diagnostic accuracy of the RBANS in mild cognitive impairment with construct-consistent measures. Applied Neuropsychology. Adult, 22(1), 32–41. https://doi.org/10.1080/23279095.2013.827574
  • Hobson, V. L., Hall, J. R., Humphreys-Clark, J. D., Schrimsher, G. W., & O’Bryant, S. E. (2010). Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS). International Journal of Geriatric Psychiatry, 25(5), 525–530. https://doi.org/10.1002/gps.2382
  • Jacova, C., Kertesz, A., Blair, M., Fisk, J. D., & Feldman, H. H. (2007). Neuropsychological testing and assessment for dementia. Alzheimer’s & Dementia: the Journal of the Alzheimer’s Association, 3(4), 299–317. https://doi.org/10.1016/j.jalz.2007.07.011
  • Karantzoulis, S., Novitski, J., Gold, M., & Randolph, C. (2013). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer’s disease. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 28(8), 837–844. https://doi.org/10.1093/arclin/act057
  • Lim, Y. Y., Maruff, P., Pietrzak, R. H., Ames, D., Ellis, K. A., Harrington, K., Lautenschlager, N. T., Szoeke, C., Martins, R. N., Masters, C. L., Villemagne, V. L., & Rowe, C. C., & Group, A. R. (2014). Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease. Brain, 137(Pt 1), 221–231. https://doi.org/10.1093/brain/awt286
  • Lundqvist, R., Lilja, J., Thomas, B. A., Lotjonen, J., Villemagne, V. L., Rowe, C. C., & Thurfjell, L. (2013). Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 54(8), 1472–1478. https://doi.org/10.2967/jnumed.112.115006
  • Marin, A., DeCaro, R., Schiloski, K., Elshaar, A., Dwyer, B., Vives-Rodriguez, A., Palumbo, R., Turk, K., & Budson, A. (2022). Home-based electronic cognitive therapy in patients with Alzheimer disease: Feasibility randomized controlled trial. Journal of Medical Internet Research, 6(9), e34450. https://doi.org/10.2196/34450
  • McDermott, A. T., & DeFilippis, N. A. (2010). Are the indices of the RBANS sufficient for differentiating Alzheimer’s disease and subcortical vascular dementia? Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 25(4), 327–334. https://doi.org/10.1093/arclin/acq028
  • Morgan, D. R., Linck, J., Scott, J., Adams, R., & Mold, J. 2010. Assessment of the RBANS Visual and Verbal Indices in a sample of neurologically impaired elderly participants. The Clinical Neuropsychologist, 24(8), 1365–1378. https://doi.org/10.1080/13854046.2010.516769.
  • Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/10.1212/wnl.43.11.2412-a
  • O’Bryant, S. E., Falkowski, J., Hobson, V., Johnson, L., Hall, J., Schrimsher, G. W., Win, O., Ngo, B., & Dentino, A. 2011. Executive functioning mediates the link between other neuropsychological domains and daily functioning: A Project FRONTIER study. International Psychogeriatrics / IPA, 23(1), 107–113. https://doi.org/10.1017/S1041610210000967.
  • O’Connell, M. E., Gould, B., Ursenbach, J., Enright, J., & Morgan, D. G. (2019). Reliable change and minimum clinically important difference (MCID) of the Repeatable Battery for the Assessment of Neuropsychology Status (RBANS) in a heterogeneous dementia sample: Support for reliable change methods but not the MCID. Applied Neuropsychology. Adult, 26(3), 268–274. https://doi.org/10.1080/23279095.2017.1413575
  • O’Mahar, K. M., Duff, K., Scott, J. G., Linck, J. F., Adams, R. L., & Mold, J. W. 2012. Brief report: The temporal stability of the repeatable battery for the assessment of neuropsychological status effort index in geriatric samples. Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists, 27(1), 114–118. https://doi.org/10.1093/arclin/acr072.
  • Ottoy, J., Niemantsverdriet, E., Verhaeghe, J., De Roeck, E., Struyfs, H., Somers, C., Wyffels, L., Ceyssens, S., Van Mossevelde, S., Van den Bossche, T., Van Broeckhoven, C., Ribbens, A., Bjerke, M., Stroobants, S., Engelborghs, S., & Staelens, S. (2019). Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18) F-FDG-PETimaging. NeuroImage Clinical, 22, 101771. https://doi.org/10.1016/j.nicl.2019.101771
  • Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., & Weiner, M. W. 2010. Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical characterization. Neurology, 74(3), 201–209. https://doi.org/10.1212/WNL.0b013e3181cb3e25.
  • Peters, A. T., Jacobs, R. H., Crane, N. A., Ryan, K. A., Weisenbach, S. L., Ajilore, O., Lamar, M., Kassel, M. T., Gabriel, L. B., West, A. E., Zubieta, J.-K., & Langenecker, S. A. (2017). Domain-specific impairment in cognitive control among remitted youth with a history of major depression. Early Intervention in Psychiatry, 11(5), 383–392. https://doi.org/10.1111/eip.12253
  • Phillips, R., Qi, G., Collinson, S. L., Ling, A., Feng, L., Cheung, Y. B., & Ng, T. P. (2015). The minimum clinically important difference in the repeatable battery for the assessment of neuropsychological status. The Clinical Neuropsychologist, 29(7), 905–923. https://doi.org/10.1080/13854046.2015.1107137
  • Porter, S., Dixon, A., Suhrie, K., Hammers, D., & Duff, K. (2021). Longitudinal changes on the Independent Living Scale in amnestic mild cognitive impairment. Applied Neuropsychology. Adult, 1–7. https://doi.org/10.1080/23279095.2021.1880409
  • Randolph, C. (2012). Repeatable Battery for the Assessment of Neuropsychological Status. The Psychological Corporation.
  • Ryan, J. J., Kreiner, D. S., Gontkovsky, S. T., & Teichner, G. (2023). Wechsler memory scale-fourth edition (WMS-IV) in the neuropsychological evaluation of patients diagnosed with probable Alzheimer’s disease. Applied Neuropsychology. Adult, 1–8. https://doi.org/10.1080/23279095.2023.2164858
  • Schmitt, A. L., Livingston, R. B., Smernoff, E. N., Reese, E. M., Hafer, D. G., & Harris, J. B. 2010. Factor analysis of the Repeatable Battery For The Assessment of Neuropsychological Status (RBANS) in a large sample of patients suspected of dementia. Applied Neuropsychology, 17(1), 8–17. https://doi.org/10.1080/09084280903297719.
  • Sunderland, J. J., & Christian, P. E. (2015). Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 56(1), 145–152. https://doi.org/10.2967/jnumed.114.148056
  • Teng, E., Ward, M., Manser, P. T., Sanabria-Bohorquez, S., Ray, R. D., Wildsmith, K. R., Baker, S., Kerchner, G. A., & Weimer, R. M. (2019). Cross-sectional associations between [(18)F]GTP1 tau PET and cognition in Alzheimer’s disease. Neurobiology of Aging, 81, 138–145. https://doi.org/10.1016/j.neurobiolaging.2019.05.026
  • Thaler, N. S., Hill, B. D., Duff, K., Mold, J., & Scott, J. G. (2015). Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) intraindividual variability in older adults: Associations with disease and mortality. Journal of Clinical and Experimental Neuropsychology, 37(6), 622–629. https://doi.org/10.1080/13803395.2015.1039962
  • Thurfjell, L., Lilja, J., Lundqvist, R., Buckley, C., Smith, A., Vandenberghe, R., & Sherwin, P. (2014). Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: Concordance with visual image reads. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 55(10), 1623–1628. https://doi.org/10.2967/jnumed.114.142109
  • Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., Hasselbalch, S., Law, I., Andersen, A., Korner, A., Minthon, L., Garraux, G., Nelissen, N., Bormans, G., Buckley, C., Owenius, R., Thurfjell, L., Farrar, G., & Brooks, D. J. (2010). 18 F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Annals of Neurology, 68(3), 319–329. https://doi.org/10.1002/ana.22068
  • Wechsler, D. (1987). Manual for the Wechsler Memory Scale - Revised. The Psychological Corporation.
  • Wessels, A. M., Lines, C., Stern, R. A., Kost, J., Voss, T., Mozley, L. H., Furtek, C., Mukai, Y., Aisen, P. S., Cummings, J. L., Tariot, P. N., Vellas, B., Dupre, N., Randolph, C., Michelson, D., Andersen, S. W., Shering, C., Sims, J. R., & Egan, M. F. (2020). Cognitive outcomes in trials of two BACE inhibitors in Alzheimer’s disease. Alzheimer’s & Dementia: the Journal of the Alzheimer’s Association, 16(11), 1483–1492. https://doi.org/10.1002/alz.12164
  • Wilkinson, G. S., & Robertson, G. J. (2006). WRAT 4: Wide Range Achievement Test, professional manual. Psychological Assessment Resources, Inc.
  • Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49.
  • Yester, M., Al-Senan, R., & White, S. (2014). NEMA testing of GE Discovery 710 PET scanner compared to a simplified protocol for routine testing of PET scanners. Journal of Nuclear Medicine, 55, 2157.
  • Zheng, B., Udeh-Momoh, C., Watermeyer, T., de Jager Loots, C. A., Ford, J. K., Robb, C. E., Giannakopoulou, P., Ahmadi-Abhari, S., Baker, S., Novak, G. P., Price, G., & Middleton, L. T. (2022). Practice effect of repeated cognitive tests among older adults: Associations with brain amyloid pathology and other influencing factors. Frontiers in Aging Neuroscience, 14, 909614. https://doi.org/10.3389/fnagi.2022.909614

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.